Non-alcoholic fatty liver disease as a cause and consequence of cardio-metabolic complications. Role of the ursodeoxicholic acid in the pharmacotherapy.
Ter Arkh
; 91(2): 109-117, 2019 Mar 18.
Article
em En
| MEDLINE
| ID: mdl-31094181
ABSTRACT
The article presents an update of the role of non-alcoholic fatty liver disease (NAFLD) in cardiometabolic diseases and events arterial hypertension and components of the metabolic syndrome. A review of NAFLD modern pharmacotherapy has been conducted. Particular attention is paid to the place of ursodeoxycholic acid in the complex treatment of NAFLD.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Ácido Ursodesoxicólico
/
Colagogos e Coleréticos
/
Síndrome Metabólica
/
Hepatopatia Gordurosa não Alcoólica
/
Hipertensão
Tipo de estudo:
Etiology_studies
/
Risk_factors_studies
Limite:
Humans
Idioma:
En
Revista:
Ter Arkh
Ano de publicação:
2019
Tipo de documento:
Article
País de afiliação:
Federação Russa